To Establish the Safety and Effectiveness of the ALPFA GRAIL PFA System for Treating Symptomatic Benign Prostate Hyperplasia (BPH) Also Known as an Enlarged Prostate.

Starting soon · Not applicable · Has a placebo group

Conditions studied: Benign Prostatic Hyperplasia (BPH)

In brief

The main goal of this study is to evaluate the ALPFA GRAIL™ Pulsed Field Ablation (PFA) System for treatment of enlarged prostate (BPH) symptoms. The study will involve up to 250 male participants who have urinary problems caused by BPH and whom are greater than 40 years of age in up to 30 investigational centers across the US,Canada and European Union.

Key facts

Study ID

NCT07592299

Run by

ALPFA Medical

People needed

250

Starts

2026-08-01

Expected to finish

2032-12-01

Last updated by the study team

2026-05-18

Who can join

Age: 45 and older. Sex: male. Healthy volunteers: not accepted.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.